Brief: Gracell Biotechnologies Net Loss Attributable To Ordinary Shareholders For Three Months Ended September 30

Gracell Biotechnologies

13/11/2023 14:16

Nov 13 (Reuters) - Gracell Biotechnologies Inc  GRCL.O :
    * GRACELL BIOTECHNOLOGIES INC: NET LOSS ATTRIBUTABLE TO
ORDINARY
SHAREHOLDERS FOR THREE MONTHS ENDED SEPTEMBER 30, 2023 WAS
RMB67.6 MILLION (US$9.3 MILLION)
    * GRACELL BIOTECHNOLOGIES INC: AS OF SEPT 30, 2023, COMPANY
HAD
RMB1,707.9 MILLION (US$234.1 MILLION) IN CASH AND CASH
EQUIVALENTS AND SHORT-TERM INVESTMENTS
    * GRACELL BIOTECHNOLOGIES INC: EXTENDED CASH RUNWAY INTO
SECOND
HALF OF 2026 WITH COMPLETION OF PRIVATE PLACEMENT OF ORDINARY
SHARES

Source text for Eikon:  ID:nGNX4vYf2Z 
Further company coverage:  GRCL.O 

 ((Reuters.Briefs@thomsonreuters.com;))